文献速递关节外科

我们已到谷底?BPCI项目如今反而不鼓励那些在照护日益复杂患者时仍保持质量的提供者

Are We at the Bottom? BPCI Programs Now Disincentivize Providers Who Maintain Quality Despite Caring for Increasingly Complex Patients.
PubMed 文献 · J Arthroplasty · 2020-07-25

该研究回顾2015至2018年9195例连续接受初次全关节置换术的 Medicare 患者,比较各年度合并症、再入院、90天诊疗费用、目标价格与利润空间,发现患者复杂度和质量维持的同时,目标价格下调导致每例利润空间从2683美元降至522美元。

要点

  • 2018年相比2015年,接受全关节置换术的患者糖尿病和心脏病患病率更高(均P < .001)。
  • 从2015到2018年,出院至康复机构比例(23% vs 14%,P < .001)和住院时间(2.1 vs 1.7天,P < .001)均下降,再入院无差异(6% vs 6%,P = .945)。
  • 每例利润空间从2683美元降至522美元(P < .001),目标价格从22280美元降至18971美元(P < .001)。

核心结论

  • 外科医生在患者复杂度增加的情况下以降低的费用维持了医疗质量。
  • 目标价格调整导致在本中心BPCI项目期间利润空间下降。
  • 政策制定者应考虑改变目标价格方法学以鼓励参与这些成功的节省费用项目。

研究设计与样本

  • 回顾性分析2015年至2018年连续9195例接受初次全关节置换术的Medicare患者,比较各年度人口学、合并症和再入院,并使用Medicare索赔数据检查90天诊疗费用、目标价格变化和财务利润空间。

主要发现

  • 2018年接受全关节置换术的患者相比2015年糖尿病和心脏病患病率更高(均P < .001)。
  • 2015年至2018年,出院至康复机构比例下降(23% vs 14%,P < .001),住院时间缩短(2.1 vs 1.7天,P < .001),再入院率无差异(6% vs 6%,P = .945)。
  • 出院后护理费用降低(6076美元 vs 4890美元,P < .001),90天诊疗费用降低(19954美元 vs 18449美元,P < .001)。
  • 目标价格也下降(22280美元 vs 18971美元,P < .001),每例利润空间缩小(2683美元 vs 522美元,P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Bundled Payments for Care Improvement (BPCI) initiative has been successful at reducing Medicare costs after total joint arthroplasty (TJA). Target pricing is based on each institution's historical performance and is periodically reset. The purpose of this study was to examine the performance of our BPCI program accounting for patient complexity, quality, and resource utilization. METHODS: We reviewed a consecutive series of 9195 Medicare patients undergoing primary TJA from 2015 to 2018. Demographics, comorbidities, and readmissions by year were compared. We then examined 90-day episode-of-care costs, changes in target price, and financial margins during the duration of the BPCI program using Medicare claims data. RESULTS: Patients undergoing TJA in 2018 had a higher prevalence of diabetes and cardiac disease (all P < .001) as compared with those in 2015. From 2015 to 2018, there was a decrease in the rate of discharge to rehabilitation facilities (23% vs 14%, P < .001) and length of stay (2.1 vs 1.7 days, P < .001) with no difference in readmissions (6% vs 6%, P = .945). There was a reduction in postacute care costs ($6076 vs $4,890, P < .001) and 90-day episode-of-care costs ($19,954 vs $18,449, P < .001). However, the target price also decreased ($22,280 vs $18,971, P < .001), and the per-patient margin diminished ($2683 vs $522, P < .001). CONCLUSION: Surgeons have maintained quality of care at a reduced cost despite increasing patient complexity. The target price adjustments resulted in declining margins during the course of our BPCI experience. Policy makers should consider changes to target price methodology to encourage participation in these successful cost-saving programs.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Krueger CA, Yayac M, Vannello C, et al. Are We at the Bottom? BPCI Programs Now Disincentivize Providers Who Maintain Quality Despite Caring for Increasingly Complex Patients. J Arthroplasty. 2020. PMID: 32800668. doi:10.1016/j.arth.2020.07.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。